HTG Announces Key First Quarter Milestone Achievements for Drug Discovery

TUCSON, Ariz. , April 18, 2023 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today announced the achievement of three significant drug discovery business milestones in the first quarter of 2023.